Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

ABVD regimen

View Patient Information

A regimen consisting of doxorubicin, bleomycin, vinblastine and dacarbazine that can be used in the treatment of Hodgkin lymphoma (HL).

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	ABVD adriamycin-bleomycin-vinblastine-dacarbazine regimen bleomycin/dacarbazine/doxorubicin/vinblastine doxorubicin/bleomycin/vinblastine/dacarbazine
Abbreviation:	BLEO/DOX/DTIC/VBL

ABVD regimen

Search NCI's Drug Dictionary